Pre-asthma: a useful concept? A EUFOREA paper. Part 2-late onset eosinophilic asthma

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064190%3A_____%2F24%3A10001241" target="_blank" >RIV/00064190:_____/24:10001241 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216208:11110/24:10483016

Výsledek na webu

<a href="https://doi.org/10.3389/falgy.2024.1404735" target="_blank" >https://doi.org/10.3389/falgy.2024.1404735</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.3389/falgy.2024.1404735" target="_blank" >10.3389/falgy.2024.1404735</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Pre-asthma: a useful concept? A EUFOREA paper. Part 2-late onset eosinophilic asthma

Popis výsledku v původním jazyce

The concept of pre-diabetes has led to provision of measures to reduce disease progression through identification of subjects at risk of diabetes. We previously considered the idea of pre-asthma in relation to allergic asthma and considered that, in addition to the need to improve population health via multiple measures, including reduction of exposure to allergens and pollutants and avoidance of obesity, there are several possible specific means to reduce asthma development in those most at risk (pre- asthma). The most obvious is allergen immunotherapy (AIT), which when given for allergic rhinitis (AR) has reasonable evidence to support asthma prevention in children (2) but also needs further study as primary prevention. In this second paper we explore the possibilities for similar actions in late onset eosinophilic asthma.

Název v anglickém jazyce

Pre-asthma: a useful concept? A EUFOREA paper. Part 2-late onset eosinophilic asthma

Popis výsledku anglicky

The concept of pre-diabetes has led to provision of measures to reduce disease progression through identification of subjects at risk of diabetes. We previously considered the idea of pre-asthma in relation to allergic asthma and considered that, in addition to the need to improve population health via multiple measures, including reduction of exposure to allergens and pollutants and avoidance of obesity, there are several possible specific means to reduce asthma development in those most at risk (pre- asthma). The most obvious is allergen immunotherapy (AIT), which when given for allergic rhinitis (AR) has reasonable evidence to support asthma prevention in children (2) but also needs further study as primary prevention. In this second paper we explore the possibilities for similar actions in late onset eosinophilic asthma.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30203 - Respiratory systems

Projekt

—

Návaznosti

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Rok uplatnění

2024

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

FRONTIERS IN ALLERGY

ISSN

2673-6101

e-ISSN

2673-6101

Svazek periodika

5

Číslo periodika v rámci svazku

5/2024

Stát vydavatele periodika

CH - Švýcarská konfederace

Počet stran výsledku

12

Strana od-do

—

Kód UT WoS článku

001233857800001

EID výsledku v databázi Scopus

2-s2.0-85194724166